Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01014741 · ClinicalTrials.gov registry record · NA
Modified Ablation Guided by Ibutilide Use in Chronic Atrial Fibrillation
A NA study, sponsored by Vivek Reddy.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT01014741 is a NA study that has completed, run by Vivek Reddy. The registered enrollment target is 200 participants.
The verdict
NCT01014741, a NA study, has completed, sponsored by Vivek Reddy.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
Procedures for ablation of persistent or long lasting atrial fibrillation are frequently long and require extensive ablation. Some electrophysiologists administer the drug ibutilide during these procedures to help organize the fibrillatory activity of the left atrium with the hope that this may shorten the length of the procedure and duration of ablation needed. Currently there is no standardized approach of administering the drug ibutilide during these procedures, thus the investigators cannot be certain that administering this drug does in fact facilitate the procedure. The aim of the MAGIC-AF Trial is to see if administering a standard dose of the drug ibutilide at a standard time in the procedure can allow for a reduction in the ablation procedure time. The investigators hypothesize that administering ibutilide during these procedures will result in a reduction in the procedure and ablation time required.
Interventions
- DRUG Placebo
- DRUG Ibutilide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2009-10 |
| Est. Completion | 2015-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01014741
The ClinicalTrials.gov registry entry for NCT01014741 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vivek Reddy, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01014741 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01014741 about?
NCT01014741 is a clinical study titled "Modified Ablation Guided by Ibutilide Use in Chronic Atrial Fibrillation". Procedures for ablation of persistent or long lasting atrial fibrillation are frequently long and require extensive ablation. Some electrophysiologists administer the drug ibutilide during these procedures to help organize the fibrillatory activity of the left atrium with the hope that this may shor...
What is the current status of trial NCT01014741?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2009-10. Estimated completion is 2015-01.
What interventions are being tested in trial NCT01014741?
The interventions under investigation include: Placebo (DRUG), Ibutilide (DRUG).
Who is sponsoring clinical trial NCT01014741?
This trial is sponsored by Vivek Reddy, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.